Memodyne Official Website › Memory Supplement Guide
Memory Supplement GuideThe memory supplement guide: what the published record supports
Four things carry randomised evidence for cognitive outcomes in adults: hearing treatment, blood-pressure treatment, physical activity and sleep. The supplement families sold for memory sit some distance behind them, and this guide sets out where each family stands, including the nitric-oxide group this product belongs to.
Written so a reader can put any product on this shelf, including this one, in its place.
What the evidence actually supports for cognition
Start with the strongest material, because it changes how everything else reads.
The 2024 Lancet standing Commission on dementia identifies fourteen modifiable risk factors across a life course. Hearing loss, high blood pressure, physical inactivity, low education, smoking, obesity, depression, social isolation, diabetes, excessive alcohol, head injury, air pollution, high LDL cholesterol and untreated vision loss. No supplement appears on that list.
The two largest randomised tests of the top two are more modest than their headlines suggest, and both are worth reading in detail rather than in summary. ACHIEVE randomised 977 adults aged 70 to 84 with untreated hearing loss to a hearing intervention or a health-education control. Across the whole cohort it did not reduce three-year cognitive decline; the benefit appeared in the higher-risk ARIC subgroup. The long-term SPRINT follow-up found probable dementia at 8.5 per 1,000 person-years on intensive blood-pressure control against 10.2 on standard care, a hazard ratio of 0.86 whose confidence interval crossed one, with mild cognitive impairment at 0.87 and the composite at 0.89.
Those are the best results in the field, and they are hedged. Anything in a bottle that promises more than that is promising more than the strongest randomised evidence in the area has delivered.
| Intervention | What was found | Trial |
|---|---|---|
| Hearing treatment | No reduction in 3-year cognitive decline across the whole cohort; benefit in the higher-risk subgroup | ACHIEVE, 977 adults aged 70 to 84 |
| Intensive blood-pressure control | Probable dementia 8.5 vs 10.2 per 1,000 person-years, hazard ratio 0.86 | SPRINT long-term follow-up |
| A daily multivitamin | A modest cognitive benefit its investigators said required replication | COSMOS-Mind and the pooled COSMOS analysis |
| Exercise | Executive function improved; type and dose analysed by network meta-analysis | A Bayesian model-based network meta-analysis |
These four are the comparison every supplement in this category should be read against.
The ingredient families sold for memory, and where each stands
Vitamins and minerals
The only family with a large randomised cognitive trial behind it as a group. COSMOS-Mind tested a daily multivitamin against placebo and found a modest benefit; the pooled COSMOS analysis came to a similar place. Both sets of authors asked for replication before recommending anything.
Nitric-oxide compounds
Arginine, arginine AKG, citrulline and citrulline malate. This is the family the product on this website belongs to. The vascular evidence is real and it is measured in blood vessels rather than in memory, at gram-scale amounts.
Cholinergic compounds
Choline donors and their relatives are the family most often associated with memory specifically. They are not on this product's label and this guide does not assess them from memory; the NCCIH review below is the place to start.
Botanical extracts
The largest and most variable family, and the one where standardisation differs most between products. Absent entirely from this particular label, which is unusual for the shelf.
Omega-3 fatty acids
Studied extensively for cognitive outcomes with mixed results. Not present here, and worth knowing about because it is the family a reader most often already takes.
Amino-acid stimulant blends
Products built around a stimulant produce an immediate subjective effect that is easily mistaken for a cognitive one. Nothing on this label is a stimulant, which is worth noting in the product's favour.
Where the nitric-oxide family is strongest, and where it is weakest
This family deserves a fair hearing rather than a dismissal, because its chemistry is better than its reputation on a memory shelf suggests.
The strength is mechanistic and it is well measured. A crossover trial in twenty healthy adults established that oral citrulline raises plasma arginine better than oral arginine does, because it escapes the intestinal arginase that destroys most of an arginine dose. A stable-isotope study showed where the arginine actually goes. That is a real and unusual piece of nutritional pharmacology.
The weakness is that every outcome measured downstream of it is vascular. Twelve weeks at 3,000 mg a day improved flow-mediated dilation, and only in participants whose blood pressure was high-normal to begin with. Four weeks at 6 g a day improved dilation, stiffness and fasting glucose in adults around 62. Nobody in these studies was given a word list to recall.
And the amounts are the problem a capsule cannot solve. Three to six grams a day of one compound is the range that produced those results. A single capsule holds a fraction of that in total, shared across everything on its label.
The mechanism is real, the vascular evidence is real, and the distance between a wider artery and a better afternoon is the part nobody has measured.The honest summary of this family
How to read any memory supplement label in five minutes
Find the amounts before the names
If there are no amounts, the comparison with any trial cannot be made, and every other feature of the label is decoration until that changes.
Look up one ingredient's trial amount
Pick the one the marketing leans on hardest. Find what a published trial used, and compare it with the label figure multiplied by the servings per day.
Check what the trial measured
A vascular endpoint, an exercise endpoint and a cognitive endpoint are three different things, and marketing copy routinely treats them as one.
Read the claim verbs
Support, help and promote are structure and function verbs. Treat, cure and prevent are drug claims, and a supplement making one is telling you something.
Find the refund window and the telephone number
These decide what happens when the product does not work, which is the most likely outcome for anything on this shelf.
Sources for this guide
- Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572-628. PMID 39096926. https://pubmed.ncbi.nlm.nih.gov/39096926/
- Lin FR, Pike JR, Albert MS, Arnold M, Burgard S, Chisolm T, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023;402(10404):786-797. PMID 37478886. https://pubmed.ncbi.nlm.nih.gov/37478886/
- Reboussin DM, Gaussoin SA, Pajewski NM, Jaeger BC, Sachs B, Rapp SR, et al. Long-term effect of intensive vs standard blood pressure control on mild cognitive impairment and probable dementia in SPRINT. Neurology. 2025;104(3):e213334. PMID 39819096. https://pubmed.ncbi.nlm.nih.gov/39819096/
- Baker LD, Manson JE, Rapp SR, Sesso HD, Gaussoin SA, Shumaker SA, Espeland MA. Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial. Alzheimers Dement. 2023;19(4):1308-1319. PMID 36102337. https://pubmed.ncbi.nlm.nih.gov/36102337/
- Vyas CM, Manson JE, Sesso HD, Cook NR, Rist PM, Weinberg A, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024;119(3):692-701. PMID 38244989. https://pubmed.ncbi.nlm.nih.gov/38244989/
- Quan J, Zhu L, Chen Z, Chen Z, Li B, Yu S. Optimal type and dose of exercise for improving executive functions in older adults: a systematic review and Bayesian model-based network meta-analysis of RCTs. BMC Geriatr. 2026;26(1):64. PMID 42260365. https://pubmed.ncbi.nlm.nih.gov/42260365/
- Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, Spickler W, Schulze F, Böger RH. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-9. PMID 17662090. https://pubmed.ncbi.nlm.nih.gov/17662090/
- Nogimura D, Nagaoka K, Ogino K, Ogino N, Moriyasu K, Morita M. Vascular effects of l-citrulline supplementation in healthy adults are largely influenced by the prehypertensive range of blood pressure: a double-blind, randomized, placebo-controlled, parallel-group study. Nutr Res. 2026;150:157-173. PMID 42142423. https://pubmed.ncbi.nlm.nih.gov/42142423/
- Kang Y, Dillon KN, Levitt DE, Figueroa A. Effects of L-citrulline supplementation on endothelial function, arterial stiffness, and blood glucose level in the fasted and acute hyperglycemic states in middle-aged and older adults with type 2 diabetes. Nutrients. 2025;17(23):3739. PMID 41374029. https://pubmed.ncbi.nlm.nih.gov/41374029/
- Mariotti F, Petzke KJ, Bonnet D, Szezepanski I, Bos C, Huneau JF, Fouillet H. Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis: insight into the arginine-nitric oxide metabolic system in humans. Am J Clin Nutr. 2013;97(5):972-9. PMID 23535108. https://pubmed.ncbi.nlm.nih.gov/23535108/
- National Center for Complementary and Integrative Health. Dietary supplements and cognitive function, dementia, and Alzheimer's disease: what the science says. Bethesda, MD. https://www.nccih.nih.gov/health/providers/digest/dietary-supplements-and-cognitive-function-dementia-and-alzheimers-disease-science
- Ambrosio G, Wirth D, Joseph JF, Mazzarino M, de la Torre X, Botrè F, Parr MK. How reliable is dietary supplement labelling? Experiences from the analysis of ecdysterone supplements. J Pharm Biomed Anal. 2020;177:112877. PMID 31568967. https://pubmed.ncbi.nlm.nih.gov/31568967/
Buy Memodyne with the whole category in view
Four things with randomised evidence, six ingredient families, and an honest account of where this one sits among them. That is the context a purchase deserves.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order Memodyne From This DeskLot MEM-26/MA-2612 · one capsule a day, 30 to a bottle · ships from the United States
